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Purpose of the study
Peripheral neuropathy and CNS neurodegeneration may
be a toxic effect of some antiretroviral nucleoside ana-
logues on mitochondria. We investigated if this neuropa-
thology may be antagonized by uridine supplementation
in vivo.
Methods
BalbC mice (7 weeks of age) were fed with zalcitabine (13
mg/kg/d) or zidovudine (100 mg/kg/d) with or without
Mitocnol (340 mg/kg/d) a dietary supplement with high
uridine bioavailability for 9 weeks. Hippocampus and
ischiadic nerve ultrastructure and mitochondrial func-
tions were assessed.
Summary of results
Zalcitabine and to a lower extent zidovudine induced a
significant peripheral and cerebral neuropathy with dis-
rupted mitochondrial architecture, depleted mitochon-
drial DNA (mtDNA), and reduced levels of cytochrome C-
oxidase activity (COX) and mtDNA-encoded cytochrome
C subunit I (COX I). Mitocnol had no side-effects but
attenuated or fully normalized all pathology of the
peripheral and central nervous system (Table 1).
Conclusion
Zidovudine and zalcitabine induce a mitochondrial
peripheral and cerebral neuropathology, both of which
are antagonized by Mitocnol.
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mtDNA copies ‡ 374 ± 49 372 ± 38 290 ± 65* 346 ± 35† 237 ± 61** 335 ± 48*†
Hippocampus
mtDNA copies ‡ 211 ± 51 219 ± 80 104 ± 32** 145 ± 21*† 151 ± 30* 181 ± 53*
COX activity @ 11 ± 3 9 ± 3 4 ± 2** 6 ± 2**† 5 ± 2** 8 ± 3*†
COX/SDH-ratio % 100 ± 9 107 ± 9 48 ± 19** 90 ± 18†† 50 ± 15** 92 ± 20††
Citrate activity @ 1152 ± 201 1086 ± 179 1124 ± 275 1265 ± 314 1791 ± 33* 1361 ± 173*†
COX II/COX IV-
ratio %
100 ± 5 122 ± 26 57 ± 25** 89 ± 22† 45 ± 20** 94 ± 20††
*, p < 0.05 vs. controls; † vs. no Mitocnol. **, p < 0.001 vs. control; †† vs. no Mitocnol; %, of control; ‡, copies/nucleus; @, μmoles/min/g protein.Page 2 of 2
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